In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after ...

Getting an expert opinion is essential after a rare cancer diagnosis like GIST, as each patient’s situation is unique, ...

An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.

The U.S. FDA granted accelerated approval to Modeyso for the patients with diffuse midline glioma with an H3 K27M mutation ...

In an interview with CURE, Clara Cirk shares the emotional weight of finishing chemo while facing ongoing immunotherapy and ...

Staci Kirk, a six-time cancer survivor, founded the Stiletto Boss Foundation to empower women through mentorship, ...

Following the June 2025 FDA approval of Datroway, Dr. Jacob A. Sands explained the significance of the regulatory approval ...

The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma ...

When my daughter had cancer, my other children carried our family with grace, compassion and strength I didn’t know I’d one ...

An expert helps patients with metastatic breast cancer understand treatment sequencing, biomarker testing and emerging ...

When treatment ended, people expected relief, but what I felt was loss, fear, and the weight of a life forever changed.

Dr. Jacob A. Sands shares how antibody-drug conjugates, such as Datroway, work to selectively target and destroy tumor cells ...